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Antiviral response pathways induce interferon by
higher-order assembly of signaling complexes called
signalosomes. Assembly of the RIG-I signalosome is
regulated by K63-linked polyubiquitin chains, which
are synthesized by the E3 ubiquitin ligase, TRIM25.
We have previously shown that the TRIM25 coiled-
coil domain is a stable, antiparallel dimer that posi-
tions two catalytic RING domains on opposite ends
of an elongated rod. We now show that the RING
domain is a separate self-association motif that en-
gages ubiquitin-conjugated E2 enzymes as a dimer.
RING dimerization is required for catalysis, TRIM25-
mediated RIG-I ubiquitination, interferon induction,
and antiviral activity. We also provide evidence that
RING dimerization and E3 ligase activity are pro-
moted by binding of the TRIM25 SPRY domain to
the RIG-I effector domain. These results indicate
that TRIM25 actively participates in higher-order
assembly of the RIG-I signalosome and helps to
fine-tune the efficiency of the RIG-I-mediated antiviral
response.INTRODUCTION
Higher-order assembly of large protein complexes is a recog-
nized signal amplification mechanism that operates in many
cellular signaling pathways (Wu, 2013). In the innate immune sys-
tem, filamentous assemblies of the mitochondrial protein, MAVS
(also known as CARDIF, VISA, or IPS-1), comprise one such type
of signalosome (reviewed by Cai and Chen, 2014). MAVS fila-
ments amplify signals from RIG-I-like pattern recognition recep-
tors bound to viral RNA and recruit downstream effectors that
ultimately generate a type I interferon (IFN) response. IFN-a/b
gene expression induced by the RIG-I/MAVS signaling axis sup-
presses the replication of a variety of clinically important viral
pathogens, including influenza A virus (IAV), hepatitis C virus,Cell
This is an open access article under the CC BY-Nand dengue virus (reviewed by Goubau et al., 2013 and Loo
and Gale, 2011).
Recent studies have shown that RIG-I-inducedMAVS filament
formation requires a remarkably simple biochemical trigger:
interaction of the amino-terminal CARD (caspase activation
and recruitment domain) of MAVS with a tetrameric assembly
of the amino-terminal tandem CARDs (2CARD) of RNA-bound
RIG-I (Jiang et al., 2012; Peisley et al., 2014; Wu et al., 2014).
The RIG-I 2CARD tetramer is a helix with a single CARD as
repeat unit, and so the 2CARD architecture restricts it to a
‘‘lock washer’’ configuration with only two helical turns (Peisley
et al., 2014). The 2CARD ‘‘lock washer’’ acts as a template or
seed for the single CARD of MAVS, which assembles along the
helical trajectory to form long filaments containing several hun-
dreds of MAVS CARD molecules (Peisley et al., 2014; Wu
et al., 2014; Xu et al., 2014). MAVS filaments behave like prion fi-
bers and thus are thought to commit the RIG-I pathway to an all-
or-none or digital response to viral infection (Cai et al., 2014; Cai
and Chen, 2014; Hou et al., 2011). Uncontrolled MAVS assembly
will have harmful consequences to the cell, and so a number of
mechanisms have evolved to regulate where, when, and how
the RIG-I 2CARD seeds MAVS CARD assembly (reviewed by
Chiang et al., 2014).
Ubiquitin (Ub) is a well-characterized regulator of the RIG-I
2CARD/MAVS CARD seeding mechanism (Gack et al., 2007,
2008; Jiang et al., 2012; Peisley et al., 2013, 2014; Zeng et al.,
2010). Activated 2CARD is modified with K63-linked polyubiqui-
tin chains (K63-polyUb) (Gack et al., 2007), and unanchoredK63-
polyUb chains were also shown to associate with RIG-I in
biochemical reconstitution studies (Jiang et al., 2012; Zeng
et al., 2010). Structural and biochemical studies have revealed
that these K63-polyUb chains can wrap around four RIG-I
2CARD molecules to induce and stabilize the ‘‘lock washer’’
configuration (Jiang et al., 2012; Peisley et al., 2014). Both types
of K63-polyUb chains are synthesized by the E3 ubiquitin ligase,
TRIM25, which is an essential component of the RIG-I pathway
(Gack et al., 2007; Zeng et al., 2010).
TRIM25 belongs to the tripartite motif (TRIM) protein family,
which is characterized by a conserved domain organization at
the N terminus (known as the TRIM or RBCC motif) composed
of a catalytic RING domain, one or two B-box domains, and aReports 16, 1315–1325, August 2, 2016 ª 2016 The Authors. 1315
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Primary Structure and E3 Ligase Activity of TRIM25
(A) Schematic of TRIM25 domain organization. Approximate amino acid boundaries of the different domains are indicated. B1, B-box 1; B2, B-box 2.
(B) Schematic of the elongated, antiparallel TRIM25 dimer, which places the catalytic RING domains around 170 A˚ apart. In this context, the RING domains are
effectively monomeric.
(C) The isolated TRIM25 RING domain is active with Ubc5 isoforms and Ubc13/Uev1A. Purified RING (5 mM), E1 (50 nM), indicated E2s (1 mM), Ub (20 mM), and
Mg-ATP (3mM) were incubated at 37C for 30min. Ubiquitination products were observed by immunoblotting (IB) with anti-Ub antibody. Figure S1 shows the full
screen of 26 different E2-conjugating enzymes, as well as a control experiment to confirm that chainsmade with Ubc13/Uev1A were not simply due to the known
E3-independent activity of this heterodimeric E2.
(D) IB analysis, using K63-linkage specific anti-Ub, of the same samples in (C).
(E) The same reactions in (C) were performed but with K63-only Ub (wherein all Ub lysines except K63 are mutated to arginine). Only K63-linked polyUb chains are
made in these reactions. IB was performed with anti-Ub.
(F) Full-length TRIM25 is active with Ubc5 and Ubc13/Uev1A. Reactions contained partially purified FLAG-tagged TRIM25 (200 nM) and either Ubc13/Uev1A
(280 nM; lanes 1–6), Ubc13 alone (1 mM; lanes 7–8), or Ubc5b alone (1 mM; lanes 9–10). IBwas performedwith anti-Ub (left) or anti-FLAG (right). TRIM25made only
unanchored K63-linked polyUb with Ubc13/Uev1A but anchored (autoubiquitinated) Ubwith Ubc13 alone or Ubc5b alone. However, faint di-Ub and tri-Ub bands
can be discerned in the Ubc5 reactions at longer exposures of the anti-Ub blot.coiled-coil dimerization domain (Meroni and Diez-Roux, 2005;
Figure 1A). In addition, TRIM25 has a C-terminal SPRY domain
that binds to the RIG-I 2CARD (D’Cruz et al., 2013; Gack et al.,1316 Cell Reports 16, 1315–1325, August 2, 20162007, 2008). TRIM proteins, like the well-characterized cullin li-
gases, are modular E3 enzymes. Similar to the cullin scaffold,
the TRIM coiled-coil domain defines the spatial disposition of
the catalytic and substrate-binding/recruitment domains. The
coiled-coil domain of TRIM25 makes an elongated, antiparallel
dimer of hairpin-shaped subunits, which positions two RING do-
mains on opposite ends of a 170-A˚-long rod (Sanchez et al.,
2014; Figure 1B). In the TRIM25 dimer, two C-terminal SPRY do-
mains emanate from a four-helix bundle in the middle of the
coiled coil. The SPRY domains are located on the same side of
the dimer, which presumably allows them to simultaneously
engage two substrate molecules (Goldstone et al., 2014; Li
et al., 2014; Sanchez et al., 2014; Weinert et al., 2015). Cooper-
ation between the catalytic and substrate-binding domains is
likely facilitated by flexible linkers connecting these domains to
the coiled-coil scaffold.
TRIM25 is recruited by RIG-I when RNA recognition by the
helicase and C-terminal domains of RIG-I releases the 2CARD
from autoinhibition (Jiang and Chen, 2011; Kowalinski et al.,
2011; Luo et al., 2011), and the exposed 2CARD binds to the
C-terminal SPRY domain of the E3 enzyme (D’Cruz et al.,
2013; Gack et al., 2007, 2008). It is not known whether 2CARD
binding is simply a mechanism to localize an already active
ligase (and therefore K63-polyUb) to sites of seed or signalo-
some assembly or whether such localization is coupled to
TRIM25 catalytic activation. Here, we use structural, biochem-
ical, and cell biological approaches to analyze the mechanism
of catalytic activation of TRIM25. We found that the RING
domain constitutes a self-association motif that dimerizes to
engage Ub-conjugated E2 enzymes and synthesize K63-pol-
yUb. Because the two RING domains in the stable, coiled-coil-
mediated TRIM25 dimer cannot self-associate and are effec-
tively monomeric, our results imply that K63-polyUb synthesis
is enabled only upon further, higher-order oligomerization of
TRIM25. This is likely to be a quality control mechanism in the
RIG-I pathway that couples TRIM25 catalytic activation to Ub-
dependent 2CARD seed formation and MAVS assembly.
RESULTS
Structure of the TRIM25 RING Domain in Complex with
E2-Ub
The antiparallel architecture of the TRIM25 coiled-coil dimeriza-
tion domain implies that the associated RING domains are sepa-
rated by about 170 A˚ and so are effectively monomeric in this
context (Figure 1B). Indeed, the TRIM25 RING was proposed
to act as a monomer, similar to the CBL-B RING domain (Li
et al., 2014). Nevertheless, many more RING domains engage
E2 enzymes as dimers, as exemplified by the non-TRIM E3 li-
gases, RNF4 and BIRC7. Structures of these proteins, each
bound to a covalent E2-Ub conjugate, have been demonstrated
to represent the catalytically primed form of these enzymes (Dou
et al., 2012; Plechanovova´ et al., 2012). We therefore reasoned
that, if the TRIM25 RING domain catalyzes K63-polyUb synthe-
sis as a dimer, then its crystal structure with the relevant E2-Ub
should reveal an equivalent quaternary fold—including high-res-
olution details—as the RNF4 and BIRC7 complexes.
To facilitate structure determination, we first identified E2-
conjugating enzymes suitable for such analysis. Two Ubc5
isoforms (Ubc5b and Ubc5c; also known as Ube2D2 and
Ube2D3, respectively) and Ubc13 (also known as Ube2N) havebeen previously shown to function in the RIG-I pathway (Liu
et al., 2013; Zeng et al., 2009, 2010). Accordingly, we found
that the isolated RING domain of TRIM25 (residues 1–83) effi-
ciently synthesized polyUb with these E2 enzymes (Figures 1C
and S1); however, K63-polyUb chains were most efficiently
made in vitro with Ubc13 and its partner, Uev1A (also known
as Ube2V1; Figures 1D and 1E). Likewise, full-length TRIM25 is
active with these E2 enzymes (Figure 1F). Interestingly, full-
length TRIM25 predominantly made anchored Ub chains (autou-
biquitination) with Ubc5b or Ubc13 alone and, conversely, only
unanchored chains with Ubc13/Uev1A.
We were successful in co-crystallizing the TRIM25 RING
domain with Ub-conjugated Ubc13 (Figure 2; Table S1). To
prevent loss of the Ub moiety during crystallization, we used
the previously described strategy of stably conjugating Ub
to the E2 via an isopeptide linkage (Plechanovova´ et al., 2012)
to make Ubc13C87K-Ub. The structure of the TRIM25 RING/
Ubc13C87K-Ub complex was determined to 2.4-A˚ resolution
(R/Rfree = 0.19/0.23).
Although the isolated TRIM25 RING domain is predominantly
a monomer in solution (Figure S2A), it crystallized as a dimer in
complex with Ubc13-Ub. This indicated that high-protein con-
centrations during crystallization and binding of Ubc13-Ub pro-
moted dimerization of the RING domain. The TRIM25 RING/
Ubc13-Ub complex is strikingly similar to the RING/E2-Ub com-
plexes of RNF4 and BIRC7 (Dou et al., 2012; Plechanovova´ et al.,
2012; Figures 2A and 2B). Each RING domain interacts with
Ubc13-Ub through an extensive three-way interface. TRIM25
Arg54 coordinates an extensive hydrogen bond network that
packs the Ub C-terminal tail against a shallow groove leading
to the E2 active site (Figure 2C), and the zinc-bound His30 side
chain makes a hydrogen bond with the Ub Glu32 carbonyl (Fig-
ure 2D). These interactions help hold Ub in the so-called
‘‘closed’’ conformation primed for catalysis (Dou et al., 2012;
Plechanovova´ et al., 2012; Pruneda et al., 2012). Complex for-
mation also induces allosteric remodeling of the E2 active site,
with the Ubc13 Asn79 side chain amide making a hydrogen
bond with the isopeptide (normally thioester) carbonyl and the
Asp119 side chain positioned to activate the incoming lysine
nucleophile (Figure 2C). Furthermore, the Ub moiety also makes
hydrogen bonds with the second RING, involving RING side
chains Glu22, Lys65, and Asn71; Ub backbone carbonyls; and
the Ub Asp32 side chain (Figure 2D). These high-resolution
structural details are very similar, and in many aspects identical,
to the previously described RING/E2-Ub complexes of RNF4
(Plechanovova´ et al., 2012) and BIRC7 (Dou et al., 2012; Figures
2B–2D). The striking equivalence of the three structures strongly
indicates that TRIM25 engages E2-Ub conjugates as a dimer.
TRIM25 RING Dimerization Is Required for Polyubiquitin
Synthesis In Vitro
The TRIM25 RING domain dimer is mediated by two regions of
contact (Figure 3A). Thr25, Asn31, and Asn66 from the zinc-bind-
ing lobes coordinate a buried hydrogen bond network, which is
contiguous with the hydrophilic interactions at the RING/E2-Ub
interface. A small four-helix bundle formed by residues that flank
the zinc lobes in primary sequence also stabilizes the dimer via
buried aliphatic side chains (Leu7, Leu11, Val68, Leu69, andCell Reports 16, 1315–1325, August 2, 2016 1317
Figure 2. Structure of the TRIM25 RING
Domain in Complex with Ub-Conjugated
Ubc13
(A) The TRIM25 RING dimer is at the center of
the complex, colored in gray and rose. Ubc13
molecules are colored in yellow and magenta. Ub
molecules are colored in cyan and green. Zinc
atoms are colored in gray. Structure statistics are
in Table S1.
(B) Superposition of the TRIM25/Ubc13-Ub com-
plex with the RNF4/Ubc5a-Ub complex (Plecha-
novova´ et al., 2012) and BIRC7/Ubc5a-Ub com-
plex (Dou et al., 2012). Proximal and distal RING
positions are defined relative to the bound Ub
(cyan). Boxed regions are expanded in (C) (blue)
and (D) (red).
(C) Details of the proximal RING interactions
showing that the TRIM25 RING dimer (left) posi-
tions the Ub tail against the E2 in the same way as
RNF4 (middle; Plechanovova´ et al., 2012) and
BIRC7 (right; Dou et al., 2012). Landmark residues
are shown as sticks and labeled. Asterisks indicate
the covalent E2-Ub linkages (isopeptide in the
TRIM25 and RNF4 complexes; oxyester in the
BIRC7 complex). Hydrogen bonds are colored in
green.
(D) Details of the distal RING interactions that help
hold Ub in the ‘‘closed’’ position primed for catal-
ysis. Also shown is a hydrogen bond between the
zinc-coordinating His30 side chain in the proximal
TRIM25 RING and Ub Glu24 carbonyl (top panel).
Both RNF4 (middle; Plechanovova´ et al., 2012) and
BIRC7 (bottom; Dou et al., 2012) make equivalent
interactions.Val72). The TRIM25 RING dimer is therefore reminiscent of the
BRCA1/BARD1 heterodimer, in that helical elements outside
the main zinc cores also mediate dimer formation (Brzovic
et al., 2001). To validate the structure, we systematically
substituted alanine for residues buried in both regions of the
TRIM25 dimer interface and then purified themutants (Figure 3B)
and tested their catalytic activity (Figure 3C). Results showed
that the RING mutants were invariably deficient in catalysis,
with L69A and V72A showing the greatest deficiency (Figure 3C).
Importantly, the size-exclusion profiles of all the RING mutants
were similar to that of the wild-type protein, indicating that the
mutants were also monomeric on purification and that none of
the mutations affected the tertiary fold of the domain (Fig-
ure S3A). Similarly, the L69A and V72A mutations did not affect
folding or the basal oligomerization of full-length TRIM25
(Figure S3B).
RING dimerization facilitates Ub conjugation because the two
RING domains cooperate in holding the Ub moiety in a configu-
ration primed for catalysis (Dou et al., 2012; Plechanovova´ et al.,
2012). The first RING interacts with both E2 and Ub using a
conserved set of interactions (Figures 2C and 2D), whereas the
second RING contacts the same Ub using a different set of
non-conserved residues (Figure 2D). In RNF4 and BIRC7, the
second set of interactions primarily consists of pi-stacking be-
tween a Ub backbone peptide and a tyrosine or phenylalanine
side chain (Figure 2D, middle and bottom panels; Dou et al.,1318 Cell Reports 16, 1315–1325, August 2, 20162012; Plechanovova´ et al., 2012). In contrast, the TRIM25 inter-
face consists of a hydrogen bond network mediated in part by
Lys65 and Asn71 (Figures 2D, top panel, and 4A). To confirm
that this set of interactions is important for catalysis, we also
generated the K65A, N71A, and N71D mutants (Figure 4B) and
assayed them for ubiquitination activity (Figure 4C). Although
the N71A mutant was still catalytically active, both the K65A
and N71D mutants were severely deficient. Thus, like RNF4
and BIRC7, the second set of RING/Ub interactions is also
required for TRIM25 catalytic activity.
In summary, the results of our structure-based mutagenesis
experiments support the conclusion that the TRIM25 RING
domain is catalytically active as a dimer. This has now been
further confirmed by an independent structure of the TRIM25
RING domain in complex with Ubc5a-Ub, which was reported
while this paper was under review (Koliopoulos et al., 2016).
The TRIM5a RING domain in complex with unconjugated
Ubc13 is also a dimer (Yudina et al., 2015), as are uncomplexed
structures of TRIM37 (PDB 3LRQ) and TRIM32 (Koliopoulos
et al., 2016), and so this may be a general property of the
TRIM family of E3 ligases.
TRIM25 RING Dimerization Is Required for RIG-I
Signaling
Our structural and biochemical analyses identified the RING
domain as a second self-association motif in TRIM25, in addition
Figure 3. Structure-Based Mutagenesis of the TRIM25 RING Dimer Interface
(A) The TRIM25 RING dimer is stabilized by a buried network of hydrogen bonds (green lines) between the two zinc lobes and by a four-helix bundle made by
residues that flank the zinc lobes in primary sequence. Residues in close contact within the dimer interface are shown as sticks and labeled.
(B) Coomassie-stained SDS-PAGE gel of purified WT and mutant recombinant RING proteins. See also Figure S3.
(C) Ubiquitination activities of the RING mutants (5 mM) with Ubc13/Uev1A (250 nM; top panels) or Ubc5b (1 mM; bottom panels). Samples were analyzed by IB
with anti-Ub.to the coiled-coil dimerization motif. We therefore sought to
examine the requirement for both types of interactions in pro-
moting RIG-I-mediated signaling. To test the signal-transducing
activities of wild-type (WT) and mutant TRIM25 proteins without
potentially confounding effects by the presence of endogenous
TRIM25 protein, we utilized CRISPR technology to generate
TRIM25-knockout (KO) HEK293T cells (Figure S4A; see Supple-
mental Experimental Procedures for details). Immunoblot (IB)
analysis confirmed the absence of endogenous TRIM25 protein
in these cells (Figure S4B). To further validate the TRIM25-KO
cells, we tested them for their ability to support RIG-I 2CARD-
mediated IFN-b promoter activation by a luciferase assay (Fig-
ure S4C). As previously shown (Gack et al., 2007), glutathione-
S-transferase (GST)-fused RIG-I 2CARD (GST-2CARD) potently
induced IFN-b promoter activation in normal (WT) HEK293T cells
due to its constitutive signal-inducing activity. In contrast, IFN-b
promoter activation induced by GST-2CARD was very low in
TRIM25-KO cells (Figure S4C). Consistent with these results,
an IAV infection assay showed low viral NS1 protein expression
in WT cells, indicative of well-controlled virus replication (Fig-
ure S4D). In contrast, the expression of IAV NS1 protein was
high in the TRIM25-KO cells, indicating that these cells are
impaired in suppressing virus replication.
To determine the signal-promoting activity of TRIM25 mu-
tants, we performed the IFN-b luciferase assay in TRIM25-
KO cells that have been transfected with GST-2CARD
together with two different amounts (1 or 5 ng) of plasmid
encoding WT or structure-based mutants of TRIM25. As pre-
viously shown (Gack et al., 2007), WT TRIM25 strongly
enhanced GST-2CARD-mediated signaling in a dose-depen-
dent manner (Figure 5A). In striking contrast, TRIM25 mutants
harboring the L69A and V72A mutations, which disrupted the
RING dimer interface, did not potentiate 2CARD-mediated
signaling; that is, IFN-b promoter activation induced by GST-2CARD co-expressed with TRIM25 L69A or V72A was similar
to that of GST-2CARD expressed alone. The lack of IFN-
b-inducing activity of the TRIM25 L69A and V72A mutants
correlated very well with loss of ubiquitination of the RIG-I
2CARD (Figure 5B), confirming that the abolished signal-pro-
moting activity of TRIM25 L69A and V72A is due to defective
E3 ligase activity.
We also tested TRIM25 proteins harboring Y245A and L252A
mutations, which severely disrupted dimerization of the isolated
coiled-coil domain (Sanchez et al., 2014). These TRIM25 mu-
tants showed only slightly reduced activities in promoting
GST-2CARD-mediated IFN-b promoter activation as compared
toWT TRIM25 at higher expression, whereas they had similar ac-
tivities to WT TRIM25 at low expression (Figure 5A). The TRIM25
coiled-coil mutants also supported GST-2CARD ubiquitination,
although this was somewhat reduced compared to WT
TRIM25, in particular for the L252A mutant (Figure 5B).
To determine the antiviral activity of TRIM25 mutants with dis-
rupted RING dimer (L69A or V72A) or coiled-coil dimer (Y245A or
L252A) interfaces, we reconstituted TRIM25-KO cells with the in-
dividual mutants and subsequently infected them with IAV. Cells
transfected with empty vector or WT TRIM25 served as controls
(Figures 5C and 5D). Cells reconstituted with WT TRIM25
potently inhibited viral titers (by more than four log) and viral
NS1 protein expression as compared to cells reconstituted
with empty vector (Vec). In contrast, cells reconstituted with
the TRIM25 L69A or V72A mutant had similar viral titers and
NS1 protein levels as vector-complemented cells, indicating a
profound defect in antiviral activity of these TRIM25 mutants.
Furthermore, cells reconstituted with the Y245A and L252A mu-
tants showed only a slightly reduced antiviral activity as com-
pared to WT TRIM25 (Figures 5C and 5D), which is consistent
with the IFN-b luciferase and 2CARD ubiquitination data (Figures
5A and 5B).Cell Reports 16, 1315–1325, August 2, 2016 1319
Figure 4. The Non-conserved Second Set of RING/Ub Interactions Is Required for Catalysis
(A) Location of Asn71 and K65 (sticks) in context of the complex.
(B) Coomassie-stained SDS-PAGE gel of purified WT and mutant recombinant RING proteins. See also Figure S3.
(C and D) Ubiquitination assays with indicated RINGmutants (5 mM) and Ubc13/Uev1A (250 nM).WT panels show corresponding control experiments, performed
in parallel. Samples were analyzed by IB with anti-Ub.The modest defect caused by the Y245A and L252A coiled-
coil dimerization mutations was somewhat surprising, because
these mutations resulted in severe misfolding of the isolated
coiled-coil domain of TRIM25, as determined by a thermal
melting assay (Sanchez et al., 2014). We therefore tested the
effect of these mutations on the thermal melting profile of full-
length TRIM25. In contrast to the isolated coiled-coil mutant
proteins, the full-length mutants were more easily purifiable
and remained dimeric, although, as expected, they were less
stable than WT (Figure S5). Thus, the folding defect caused by
Y245A and L252A was much less pronounced in context of
full-length TRIM25, explaining the modest effect of these muta-
tions in the cell-based assays. We surmise that the presence
of eukaryotic chaperones during expression of the full-length
mutants likely compensates for the folding and dimerization
defect caused by the coiled-coil mutations.
Analysis of TRIM25 Self-Association in Solution
The above results indicated that the stable, coiled-coil-mediated
TRIM25 dimer (Sanchez et al., 2014) is insufficient for catalysis
and that engagement of the E2-conjugating enzyme and polyUb
synthesis occurs with further, higher-order assembly of the
ligase. Indeed, TRIM5a, another antiviral TRIM family member,
becomes catalytically active precisely by this mechanism.
Higher-order assembly of TRIM5a is mediated by its single
B-box domain, which facilitates spontaneous assembly of
coiled-coil-mediated TRIM5a dimers into an extended lattice
(Diaz-Griffero et al., 2009; Ganser-Pornillos et al., 2011; Li and
Sodroski, 2008; Li et al., 2016; Wagner et al., 2016). Note that,
in contrast to TRIM5a, TRIM25 has a tandem of B-boxes (Fig-
ure 1A). To determine whether TRIM25 also assembles sponta-
neously in a B-box-dependent manner, we analyzed the solution
behavior of full-length TRIM25 (Figures S2B and S2C). Notably,
we found that full-length TRIM25 had significant E3 ligase activ-
ity at nanomolar concentrations (Figure 1F). This was in contrast
to the isolated RING domain, which catalyzed polyUb formation
only at micromolar concentrations (Figure 1C) and suggested
that, in context of the full-length protein, RING-RING interactions
occurred more readily. We have previously shown that the iso-
lated coiled-coil domain of TRIM25 is a stable dimer in solution,
and indeed, freshly purified full-length TRIM25 also behaved as a1320 Cell Reports 16, 1315–1325, August 2, 2016stable dimer at low-protein concentrations (Figure S2B). Inter-
estingly, at higher concentrations, we reproducibly detected
the presence of a minor species with molecular weight consis-
tent with a tetramer (Figure S2C). However, extensive analysis
by electron microscopy did not reveal convincing evidence of
spontaneous higher-order or lattice-type assembly behavior
for TRIM25. These results indicated that unlike the B-box 2
domain of TRIM5a, the equivalent domain in TRIM25 does
not spontaneously self-associate. We conclude that efficient
TRIM25 RING domain activation is likely to be facilitated by other
factors.
RIG-I 2CARD Enhances TRIM25’s Catalytic Activity
In Vitro
What might be the factors that promote assembly of catalytically
active TRIM25? Our data indicate that a minimum of two coiled-
coil-mediated TRIM25 dimers (or four monomers) is required to
generate a catalytically active E3 ligase. This matches the stoi-
chiometry of the 2CARD tetramer that seeds MAVS filament as-
sembly. Therefore, an appealing hypothesis is that TRIM25 and
RIG-I mutually promote each other’s oligomerization and activa-
tion. Indeed, it has been demonstrated that K63-linked poly-Ub
chains synthesized by TRIM25 can promote 2CARD tetrameriza-
tion in vitro (Peisley et al., 2014). We therefore performed the
complementary experiment to ask whether 2CARD promotes
higher-order oligomerization and catalytic activation of TRIM25.
We first titrated TRIM25 concentrations in our ubiquitination
reactions and found that, with 100 nM of full-length TRIM25,
poly-Ub chain formation was minimal with either Ubc13/Uev1A
(Figure 6A, lane 3) or Ubc5c (Figure 6A, lane 7). The same reac-
tions were then performed in the presence of 1 mM of freshly pu-
rified His-tagged 2CARD, and we found that polyUb synthesis
was very significantly enhanced (Figure 6A, compare lane 4 to
lane 3 and lane 8 to lane 7). Thus, RIG-I 2CARD can promote
TRIM25 RING/RING self-association in vitro and, by implication,
higher-order oligomerization of coiled-coil-mediated TRIM25
dimers.
To determine whether polyUb-mediated 2CARD tetrameriza-
tion was required for this effect, we measured catalysis using a
Ub discharge assay in which polyUb chains were not being
made (Middleton et al., 2014). In this assay, E2-Ub conjugates
Figure 5. IFN Induction, Ubiquitination, and Antiviral Activities of
TRIM25
(A) IFN-b induction by WT and TRIM25 mutants. TRIM25-KO HEK293T cells
(Figure S4) were transfected with plasmids encoding IFN-b-luciferase,
b-galactosidase, GST, or GST-2CARD and empty vector (Vec) or the indicated
FLAG-tagged TRIM25 (T25) constructs (see Experimental Procedures for
details). Twelve hours later, IFN-b promoter activity was measured by a
luciferase assay and values were normalized to b-galactosidase. Whole-cell
lysates (WCLs) were analyzed by IB with the indicated antibodies. Results are
expressed as mean ± SD (n = 2).
(B) Ubiquitination of RIG-I 2CARD. TRIM25-KO HEK293T cells were trans-
fected with plasmid for GST or GST-2CARD, together with Vec or the indicated
FLAG-TRIM25 constructs. Forty-eight hours later, cells were lysed and WCLs
subjected to GST pull-down (GST-PD), followed by IB with anti-Ub and anti-
GST antibodies. IB of WCLs was performed with anti-FLAG antibody to
determine the expression levels of the TRIM25 WT and mutant proteins.
(C and D) Replication of influenza A virus (IAV) (H1N1 PR8 strain) in TRIM25-KO
HEK293T cells reconstituted with TRIM25 WT or mutants. Cells were trans-
fected with Vec or plasmids encoding FLAG-tagged TRIM25 WT or the indi-
cated mutants. At 24 hr post-transfection, cells were infected with IAV (MOI
0.01) for 96 hr. Expression levels of IAV NS1, actin, and TRIM25 constructs
were analyzed by IB with anti-NS1, anti-actin, and anti-FLAG (TRIM25) anti-
bodies (C). IAV titers in the supernatant of reconstituted TRIM25-KO cells were
determined by TCID50 assay (D). The results shown are from two independent
experiments.were first synthesized by incubation of E1 and E2 enzymes with
Ub and ATP. Discharge of the Ub moiety was then monitored
by the disappearance of the E2-Ub conjugate and appearance
of free E2, under conditions that prevent re-charging of the
E2. To slow down the reaction, we used oxyester-linked
Ubc5bS22R/C85S-Ub conjugates and did not add excess Ub
acceptor amine (Middleton et al., 2014; Wright et al., 2016). In
this assay format, we found that TRIM25 did not significantly in-
crease the basal rate of free E2 accumulation, probably because
dissociation of the RING/RING dimer or RING/E2-Ub complex
was fast relative to oxyester cleavage. We then found that
the presence of 2CARD also did not result in increased
discharge (Figure 6B), even though we used a GST-2CARD
fusion protein that was already dimeric due to the GST tag. On
the other hand, when the addedGST-2CARDwas pre-incubated
with K63-linked tetraUb, TRIM25-mediated discharge was in-
creased. The effect was modest but was nevertheless evident,
especially when comparing the initial time points (30–90 s), and
was reproducibly observed in two independent experiments per-
formed with independent protein preparations (Figure 6B).
Because incubation with K63-linked polyUb chains induces
2CARD tetramerization in vitro (Peisley et al., 2014), these results
indicated that the presence of the 2CARD tetramer also stabi-
lized the TRIM25 RING dimer and/or RING/E2-Ub complexes,
i.e., that 2CARD oligomerization and TRIM25 oligomerization
can occur cooperatively.
Finally, we found that mutation of T55 in the first CARD,
which is a critical residue for TRIM25 SPRY domain binding
(Gack et al., 2008), did not increase TRIM25-mediated Ub
discharge, even when the mutant GST-2CARD was pre-incu-
bated with K63-linked polyUb (Figure 6B). This result con-
firmed expectation that RIG-I 2CARD-mediated TRIM25 acti-
vation is dependent on binding of 2CARD to the SPRY
domain of TRIM25.Cell Reports 16, 1315–1325, August 2, 2016 1321
Figure 6. RIG-I 2CARD Enhances TRIM25’s Catalytic Activity In Vitro
(A) Ubiquitination activity of 100 nM FLAG-TRIM25 in the presence or absence of His-tagged RIG-I 2CARD. Reaction mixtures were analyzed by IB with anti-Ub
(top), anti-FLAG (middle), and anti-His (bottom). As with the autoubiquitination reactions, substrate-attached Ub was observed only with Ubc5b and not with
Ubc13/Uev1A. This experiment was performed with five independent protein preparations, with similar results.
(B) Oxyester hydrolysis assays showing the disappearance of Ubc5bS22R/C85S-Ub conjugates and the appearance of free Ubc5b in the presence of full-length
TRIM25 (1 mM), GST-tagged WT or T55D RIG-I 2CARD (8 mM), and/or K63-linked tetraUb (5 mM) over 180 min. (Top) Samples were resolved by using non-
reducing SDS-PAGE and Coomassie blue staining. Experiments were performed in duplicate, and one set is shown. (Bottom) Densitometry quantification of gels
follows the appearance of free Ubc5b over time. Error bars show the range values obtained in two independent experiments, performedwith independent protein
preparations of both TRIM25 and 2CARD.DISCUSSION
The essential role of TRIM25 in the RIG-I pathway is underscored
by findings that viruses, such as IAV and dengue virus, have
evolved mechanisms to suppress RIG-I signaling by specifically
targeting and disrupting TRIM25 function (Gack et al., 2009;
Manokaran et al., 2015; Rajsbaum et al., 2012). In this study,
we confirm the essential requirement for TRIM25’s E3 ubiquitin
ligase activity in RIG-I signaling (Gack et al., 2007) by showing
that mutations that disrupt TRIM25 RING domain activation
also reduce to background levels the ubiquitination of RIG-I
2CARD, 2CARD-dependent IFN induction, and antiviral activity
against IAV. Furthermore, our results show that the TRIM25
RING domain must dimerize in order to productively engage
Ub-conjugated E2 enzymes and become catalytically active,
which is a common (but not universal) property of the RING fam-
ily of E3 ubiquitin ligases (Lima and Schulman, 2012). Like other
TRIM proteins, the basal oligomeric state of TRIM25 is a stable,
coiled-coil-mediated dimer (Goldstone et al., 2014; Li et al.,
2014; Sanchez et al., 2014; Weinert et al., 2015). The TRIM25
coiled-coil dimer has an antiparallel architecture, which places
the two associated RING domains on opposite ends of an elon-
gated rod (Sanchez et al., 2014). Therefore, TRIM25 RING di-
mers very likely form by means of higher-order oligomerization
(or assembly) of the coiled-coil-mediated dimers.
We envision at least two possible types of assembled, catalyt-
ically active TRIM25: a tetramer form wherein one coiled-coil-
mediated dimer would interact with a second to allow head-to-1322 Cell Reports 16, 1315–1325, August 2, 2016head interactions of their RING domains or a filamentous or
net form wherein the RING domains on opposite ends of the
coiled coil would interact with RING domains from separate di-
mers (Figure 7). TRIM5a, another well-characterized TRIM pro-
tein, makes higher-order complexes by the second mechanism;
in this case, individual N-terminal RING domains are brought into
close proximity by spontaneous trimerization of the downstream
B-box 2 domains and assembly of TRIM5a dimers into an
extended hexagonal network (Ganser-Pornillos et al., 2011; Li
et al., 2016;Wagner et al., 2016; Yudina et al., 2015). Our analysis
did not reveal a similar type of spontaneous high-order assembly
behavior for TRIM25, indicating that its RING domains are
brought into proximity by a different mechanism.
Initial recognition of viral RNA by RIG-I occurs at a tri- or di-
phosphorylated blunt end of the viral RNA (Cui et al., 2008;
Goubau et al., 2014; Hornung et al., 2006; Jiang and Chen,
2011; Kowalinski et al., 2011; Luo et al., 2011; Pichlmair et al.,
2006). Multiple RIG-I molecules can decorate the same RNA (if
it is of sufficient length) in an ATP-dependent manner (Peisley
et al., 2013). This property of RIG-I is thought to promote
clustering of activated 2CARDs, because a minimum of four
2CARD molecules is required to seed MAVS CARD filament
assembly and initiate signaling (Peisley et al., 2014; Wu et al.,
2014). We found that, at least in vitro, the isolated 2CARD
can promote TRIM25 catalytic activation, in a manner that ap-
pears dependent on binding of 2CARD to the TRIM25 SPRY
domain. These results indicate that RIG-I assembly on the viral
RNA has the additional purpose of recruiting and clustering
Figure 7. TRIM25 RING Dimerization
Shown are two possible modes of higher-order
assembly of coiled-coil-mediated TRIM25 protein
dimers that will promote RING/RING dimerization.
The domains are color-coded as follows: red,
RING (R); orange, B-boxes (B); green, coiled coil;
blue, SPRY (S).multiple TRIM25 dimers to activate K63-polyUb synthesis. Such
a coupled recruitment and activation mechanism avoids any po-
tential off-pathway effects of polyUb chains because these are
synthesized only when needed and at the correct location.
Furthermore, we propose that mutually productive engage-
ment of RIG-I and TRIM25 goes beyond simple proximity-
induced self-association and activation. Because 2CARD-medi-
ated enhancement of TRIM25 activity in vitro is also dependent
on polyUb, it is very likely that formation of the tetrameric
2CARD seed is cooperative with TRIM25 RING dimerization
and catalytic activation. Indeed, it is probable that there is an
avidity component to the interaction, because a head-to-head
TRIM25 tetramer should cluster four SPRY domains and allow
simultaneous, stoichiometric SPRY/2CARD binding. A coopera-
tive assembly mechanism is consistent with the finding that
TRIM25, RNA-bound RIG-I, and the chaperone protein 14-3-3ε
make a stable ternary complex that translocates from the cytosol
to mitochondria in order to activate MAVS (Liu et al., 2012).
In summary, our results help to explain why TRIM25 is an
essential player in the RIG-I-signaling pathway. In addition to
its role as an enzymatic effector of RIG-I, TRIM25 confers addi-
tional biochemical functionalities that promote 2CARD tetrame-
rization and signal propagation. TRIM25 therefore helps to fine-
tune the efficiency of RIG-I-mediated signaling to high degree,
which is an important property that allows the pathway to
respond effectively even if viral challenge is low.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Detailed methods to purify proteins and characterize them by analytical ultra-
centrifugation and size exclusion chromatography and multi-angle light scat-
tering (SEC-MALS) are described in Supplemental Experimental Procedures.
Ubiquitination Assay
E1 and E2 enzymes and Ub were either purified in house or purchased from
Boston Biochem, UBPBio, or Enzo Life Sciences. Ubiquitination reactions
were incubated at 37C in 50 mM Tris (pH 7.5), 150 mM NaCl, 0.5 mM tris(2-
carboxyethyl)phosphine (TCEP), or 1 mM b-mercaptoethanol and typically
contained E1 (50 or 100 nM), E2 (280 nM Ubc13/Uev1A, 1 mM Ubc13, or
1 mM Ubc5b), E3 (200 nM TRIM25 or 5 mM RING), Ub (40 mM), ATP (3 mM),
and MgCl2 (5 mM). Reactions were stopped by addition of SDS-PAGE sample
buffer and boiling for 10 min. Typically, time points were taken at 0, 5, and/or
20 min. Immunoblots were performed with anti-Ub (1:2,000; P4D1; Santa Cruz
Biotechnology), K63-linkage-specific anti-Ub (1:1,000; Enzo Life Sciences),
anti-pentaHis (1:1,000; QIAGEN), and anti-FLAG M2 (1:5,000; Sigma). Signals
were detectedwith a fluorescent secondary antibody (Rockland) and a LI-COR
Odyssey scanner.
Ubiquitin Discharge Assay
This assay was performed essentially as described (Wright et al., 2016).
Ubc5bS22R/C85S-Ub oxyester-linked conjugate was prepared by mixing thefollowing: 200 mM Ubc5b, 300 mM Ub, 1 mM E1, 50 mM Tris (pH 7.5),
150 mM NaCl, 5 mM ATP, 5 mM MgCl2, 0.5 mM TCEP, and 0.1% Triton
X-100. After overnight incubation at 37C, the E1 enzyme and free ATP were
removed by gel filtration in 20 mM Tris (pH 7.5) and 150 mM NaCl. Fractions
containing E2-Ub, free E2, and free Ub were collected and concentrated
to 4 mg/ml (53 concentration). Discharge reactions containing 13
Ubc5bS22R/C85S-Ub, 1 mM TRIM25, and 8 mM GST-2CARD (WT or T55D),
with or without 5 mM K63-linked tetraUb (Boston Biochem) in 50 mM Tris
(pH 7.5) and 50 mM NaCl were incubated at 37C. Time points were taken
every 30 min over 3 hr and quenched by addition of non-reducing SDS-
PAGE and subsequent placement on ice. Reactions products were visualized
by SDS-PAGE and Coomassie staining. Free Ubc5bS22R/C85S was quantified
by using a LI-COR Odyssey scanner. The experiment was performed twice,
each with freshly purified batches of TRIM25 and 2CARD.
Structure Determination of the TRIM25 RING/Ubc13-Ub Complex
The purified RING and Ubc13C87K-Ub conjugate samples were diluted to
20 mM using their respective size exclusion buffers, mixed at equal volumes,
and then concentrated to 10 mg/ml. Crystallization was performed in sitting
drops with commercial screens at a 2:1 protein-to-precipitant ratio. Crystals
formed in Hampton PEG/Ion HT Screen condition no. D9 (0.2 M Li citrate
and 20% polyethylene glycol (PEG) 3,350) after 2 days and were used for
data collection without optimization. Ethylene glycol (10% [v/v] in mother li-
quor) was used as cryoprotectant. Diffraction data collected at beamline
5.0.1 at the Advanced Light Source were indexed and scaled using
HKL2000 (Otwinowski and Minor, 1997).
The phase problemwas solved bymolecular replacement with crystal struc-
tures of human Ubc13 (PDB 1J7D) and Ub (PDB 1UBQ). The Ubc13 active site
loop and Ub tail were removed from the search models to obtain unbiased
densities for these regions. After positioning of the Ubc13 and Ub moieties,
rigid body refinement also revealed strong densities for the zinc atoms in the
RING domains as well as coordinating side chains and associated loops.
These served as guides for calculation of 2-fold noncrystallographic symmetry
(NCS) averaged maps, which were used to build the RING domains. Iterative
refinement and manual model building were performed with PHENIX (version
1.9-1692; Adams et al., 2010) and Coot (Emsley et al., 2010). Secondary struc-
ture, torsion angle NCS, covalent bond and angle restraints for the Ubc13 K87-
Ub G76 isopeptide, and zinc coordination (bond and angle) restraints were
applied during refinement. Structure validation tools (as implemented in
PHENIX and Coot) were used throughout the refinement process. Structure
statistics are summarized in Table S1.
Cell Culture
Plasmids and viruses, cell culture methods, and generation of TRIM25-KO
HEK293T cells are described in Supplemental Experimental Methods.
IFN-b Luciferase Assay
TRIM25-KO HEK293T cells were seeded into 24-well plates. The next day, the
cells were transfected with 100 ng of IFN-b luciferase reporter plasmid and
150 ng of b-galactosidase-expressing pGK-b-gal. To stimulate IFN-b pro-
moter activity, cells were also transfected with 1 ng of plasmid encoding
GST-2CARD together with 1 or 5 ng of empty pCMV vector or pCMV-FLAG-
TRIM25 WT or mutant constructs. Twelve hours later, whole-cell lysates
(WCLs) were prepared and subjected to a luciferase assay (Promega). Lucif-
erase values were normalized to b-galactosidase activity tomeasure the trans-
fection efficiency.Cell Reports 16, 1315–1325, August 2, 2016 1323
GST Pull-Down Assay and Immunoblot Analysis
Pelleted cells were lysed in NP-40 buffer (50 mM HEPES [pH 7.4], 150 mM
NaCl, 1% [v/v] NP-40, and protease inhibitor cocktail [Roche]), followed by
centrifugation at 13,000 rpm for 25 min. Lysates were mixed with a 50% slurry
of glutathione-conjugated Sepharose beads (GE Healthcare), and the binding
reaction was incubated for 3 hr at 4C. Precipitates were washed extensively
with lysis buffer. Proteins bound to the beads were separated by SDS-PAGE
and transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad). Im-
munoblots were performed with anti-Ub (1:5,000; P4D1; Santa Cruz), anti-
FLAG (1:2,000; Sigma), anti-GST (1:2,000; Sigma), anti-RIG-I (1:1,000; Adipo-
gen), anti-TRIM25 (1:2,000; BD Biosciences), anti-actin (1:5,000–1:15,000;
Sigma), or anti-NS1 (polyclonal rabbit; 1:3,000; kindly provided by Adolfo Gar-
cı´a-Sastre, Mount Sinai). The proteins were visualized by a chemilumines-
cence reagent (Pierce) and detected with a GE Healthcare Amersham Imager.
Influenza Replication Assays
TRIM25-KO HEK293T cells, seeded into 12-well plates, were transfected with
2 mg of pCMV empty vector or pCMV-FLAG-TRIM25WT or mutant constructs.
At 24 hr post-transfection, cells were infected with IAV (MOI 0.01) for 96 hr. To
determine viral titers, supernatants were subjected to an endpoint titration
(TCID50) assay on MDCK cells in DMEM supplemented with Pen-Strep,
0.2% BSA (Sigma), 25 mM HEPES, and 2 mg/ml TPCK-trypsin (Worthington
Biochemical), as described previously (Balish et al., 2013). Furthermore, cells
were harvested andWCLs prepared and subjected to SDS-PAGE and IB anal-
ysis using anti-NS1, anti-FLAG, and anti-actin antibodies.
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